Great Novel Therapeutics Biotech & Medicals (TPEX:7427)
Taiwan · Delayed Price · Currency is TWD 72.60
+0.70 (0.97%)
Aug 17, 2026, 1:58 PM CST
TPEX:7427 Market Cap
TPEX:7427 has a market cap or net worth of 3.08 billion as of August 17, 2026. Its market cap has increased by 113.71% in one year.
Market Cap
3.08B
Enterprise Value
2.64B
Revenue
1.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
72.60
ChartMarket Cap Chart
Since July 8, 2021, TPEX:7427's market cap has increased from 1.48B to 3.08B, an increase of 108.27%. That is a compound annual growth rate of 15.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 2.89B | 110.43% |
| Dec 31, 2025 | 1.37B | -7.37% |
| Dec 31, 2024 | 1.48B | -42.09% |
| Dec 29, 2023 | 2.56B | 40.55% |
| Dec 30, 2022 | 1.82B | 94.83% |
| Dec 30, 2021 | 935.73M | -36.72% |
| Jul 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Formosa Pharmaceuticals | 3.47B |
| Senhwa Biosciences | 3.47B |
| OBI Pharma | 3.47B |
| SYN-TECH Chem. & Pharm. | 3.32B |
| Sagittarius Life Science | 3.31B |
| BioGend Therapeutics | 3.14B |
| Shine-On BioMedical | 3.13B |
| Apex Biotechnology | 3.08B |